Arch Therapeutics (ARTH) Starts Presentation at Biotech Showcase Conference

Arch Therapeutics (NASDAQ: ARTH), a medical device company, offers an innovative approach to rapid cessation of bleeding and control of fluid during surgery and trauma care. The underlying technology, exclusively licensed from a leading university, supports an innovative platform of smart materials that fulfill the criteria as a solution for a specialized field called: stasis and barrier applications. For more information, visit the company’s website at www.archtherapeutics.com.